Cancer & Personalized Medicine Conference

Cancer & Personalized Medicine Conference

A Policy Debate on the Value & Cost of Treatment

Innovations in cancer therapy, particularly the development of targeted drugs and immunotherapies, hold remarkable potential to transform treatment of the disease. Increasingly, a new generation of cancer drugs is producing durable remissions and, potentially, cures. However, defining the value of cancer drugs is challenging. Numerous factors influence value, and the relative importance of each of these factors depends on the perspective of the stakeholders (patients, society, providers, payers, healthcare systems, manufacturers, researchers and academics). Though the needs of all stakeholders should be considered, patient benefit must be central when assessing value.


Participation fees with Early Bird Until 19 September  

Individual participation250€ + 24% VAT
4 Company registrations (3+1 free): 750€ + 24% VAT
8 Company registrations (6+2 free)1500€ + 24% VAT


Participation fees after 19 September  

Individual participation300€ + 24% VAT
4 Company registrations (3+1 free): 900€ + 24% VAT
8 Company registrations (6+2 free)1800€ + 24% VAT


Early Bird Conference Ticket € 250,00
Full Price Conference Ticket € 300,00
Free Conference Ticket

Public servants, Nurses, Pharmacists, Academics and Researchers, Patient group representatives.

DOCTOR Conference Ticket (Free)
STUDENT Conference Ticket (Free)

Ο ΦΠΑ δεν περιλαμβάνεται


Πέμπτη, 17 Οκτωβρίου 2019 9:00 πμ



Central Athens Regional Unit, Greece

Προβολή μεγαλύτερου χάρτη